Time-course remodeling and pathology intervention of α-synuclein amyloid fibril by heparin and heparin-like oligosaccharides
Nature Structural & Molecular Biology · 2025
DOI: 10.1038/s41594-024-01407-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Structural & Molecular Biology, 2025. Verfasst von Youqi Tao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong Universi…. Hauptthemen laut MEDLINE: alpha-Synuclein, Heparin, Amyloid, Oligosaccharides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Amyloid fibrils represent a pathological state of protein polymer that is closely associated with various neurodegenerative diseases. Polysaccharides have a prominent role in recognizing amyloid fibrils and mediating their pathogenicity. However, the mechanism underlying the amyloid-polysaccharide interaction remains elusive. We also do not know its impact on the structure and pathology of formed fibrils. Here, we used cryo-electron microscopy to analyze the atomic structures of mature α-synuclein (α-syn) fibrils upon binding with polymeric heparin and heparin-like oligosaccharides. The fibril structure, including the helical twist and conformation of α-syn, changed over time upon the binding of heparin but not oligosaccharides. The sulfation pattern and numbers of saccharide units are important for the binding. Similarly, negatively charged biopolymers typically interact with amyloid fibrils, including tau and various α-syn polymorphs, leading to alterations in their conformation. Moreover, we show that heparin-like oligosaccharides can not only block neuronal uptake and propagation of formed α-syn fibrils but also inhibit α-syn fibrillation. This work demonstrates a distinctive activity of heparin and biopolymers in remodeling amyloid fibrils and suggests the pharmaceutical potential of heparin-like oligosaccharides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
- State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
- Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai, China.
- Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
- State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. byu@sioc.ac.cn.
- State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. liulab@sioc.ac.cn.
Zitieren
APA
Tao, Y., Xu, P., Zhang, S., Shangguan, W., Yang, G., Liu, K., Li, X., Sun, Y., Zhao, Q., Li, D., Yu, B., & Liu, C. (2025). Time-course remodeling and pathology intervention of α-synuclein amyloid fibril by heparin and heparin-like oligosaccharides. Nature Structural & Molecular Biology. https://doi.org/10.1038/s41594-024-01407-2
Vancouver
Tao Y, Xu P, Zhang S, Shangguan W, Yang G, Liu K, et al. Time-course remodeling and pathology intervention of α-synuclein amyloid fibril by heparin and heparin-like oligosaccharides. Nature Structural & Molecular Biology. 2025. doi:10.1038/s41594-024-01407-2
BibTeX
@article{Tao2025,
author = {Tao, Youqi and Xu, Peng and Zhang, Shenqing and Shangguan, Wei and Yang, Guang and Liu, Kaien and Li, Xiang and Sun, Yunpeng and Zhao, Qinyue and Li, Dan and Yu, Biao and Liu, Cong},
title = {Time-course remodeling and pathology intervention of α-synuclein amyloid fibril by heparin and heparin-like oligosaccharides},
journal = {Nature Structural & Molecular Biology},
year = {2025},
doi = {10.1038/s41594-024-01407-2}
}
EUVIMED